Physician profile
Carla Goga
NPI 1518465343
$2,216.47
in general payments reported to CMS, 2019-2025
21 companies · $555 in 2025
The $555 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253 · 2022: $403 · 2023: $601 · 2024: $404 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $453.47 | 2022-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $242.21 | 2021-2025 | Phexxi, Solosec, Phexx |
| Biogen, INC. | $206.85 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $190.65 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $186.75 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $174.66 | 2021-2025 | |
| Abbvie INC. | $146.22 | 2021-2022 | |
| Myovant Sciences INC. | $114.42 | 2021-2022 | |
| Organon LLC | $102.81 | 2022-2025 | Nexplanon |
| Medtronic, INC. | $64.00 | 2021-2023 | Truclear, Venaseal |
| Coopersurgical, INC. | $52.49 | 2022-2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $50.63 | 2025 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Avion Pharmaceuticals | $43.00 | 2023 | Divigel |
| Dexcom, INC. | $35.60 | 2025 | Dexcom G6 Transmitter |
| Optumhealth Care Solutions, LLC | $34.09 | 2023-2024 | Zyno Solutions, Vivify Health Care Team Portal, Vivify Health Care Team Portal 001 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $30.14 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Novo Nordisk INC | $18.17 | 2025 | Rybelsus, Ozempic |
| Davol INC. | $17.79 | 2021 | |
| Mylan Pharmaceuticals INC. | $17.68 | 2022 | |
| Exeltis, USA INC. | $17.58 | 2025 | Slynd |
| Pfizer INC. | $17.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Goga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.